Key result
Mediastinal radiotherapy was safely delivered to a patient with an implanted cardiac pacemaker by restricting the cumulative dose to the pacemaker to 1.15 Gy, maintaining normal pacemaker function at 2.5 years follow-up.
Why the study?
Delivering radiotherapy to patients with implanted pacemakers is challenging when treatment portals are close to the pacemaker, requiring cumulative doses below 2 to 5 Gy.
Case Report (n=1)
No
Radiotherapy can be safely delivered to patients with cardiac pacemakers by following a structured algorithm to keep the cumulative dose to the device below 2 Gy.
Answers are grounded in this paper and cite their sources.
Requires individualized dosimetry planning for safe mediastinal RT near pacemakers; leaves open generalizability beyond single cases.
Background: There are clinical scenarios when it is required to deliver Radiotherapy (RT) to patients who have implanted pacemakers and it is challenging when treatment portals are close to pacemaker. The cumulative dose to the pacemaker needs to be less than 2 to 5 Gy as per the current recommendations.Aim and Methods: To describe the steps undertaken for safe delivery of mediastinal radiotherapy for a patient with Hodgkin’s lymphoma and implanted pacemaker. Case presentation: Sixty-year-old gentleman who had implanted dual-chamber rate adaptive (DDDR), magnetic resonance imaging (MRI) compatible, permanent pacemaker for complete heart block presented with lymphadenopathy and was diagnosed with Classical Hodgkin’s Lymphoma stage IV. He received consolidation RT (30 Gy in 15 fractions) to the mediastinum after completion of chemotherapy. An algorithm was developed based on AAPM (The American Association of Physicists) report for necessary steps to be taken at various stages of radiotherapy planning and treatment delivery. This approach made it possible to reduce cumulative dose to the pacemaker to < 2Gy.Conclusion: RT can be safely delivered to the patients with cardiac pacemakers. Close follow-up of the patients in conjunction with the Cardiologist, before, during and after radiation is essential for the patient’s safety.
No takes yet. Share an insight, caveat, or question.
Sidhique et al. (2022) conducted a case report in Classical Hodgkin's Lymphoma and implanted cardiac pacemaker (n=1). Mediastinal radiotherapy was evaluated on Cumulative radiation dose to the pacemaker and pacemaker function. Mediastinal radiotherapy was safely delivered to a patient with an implanted cardiac pacemaker by restricting the cumulative dose to the pacemaker to 1.15 Gy, maintaining normal pacemaker function at 2.5 years follow-up.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: